Given the role of TNF-α in the pathogenesis of RA, TNF-α blockade therapy (TNFi) with Enbrel suppressed miR-182 expression levels and elevated PKR and IFN-β expression levels, and decreased osteoclastogenesis in RA patients-derived PBMCs. Here, EIF2AK2 is linked to rheumatoid arthritis.